A new project, co-funded with EUR8.5m from the European Commission is underway to accelerate the development of new vaccines, drugs and microbicides to fight against many poverty-related diseases such as tuberculosis (TB), HIV, malaria, ...
Tags: Poverty Related Diseases, Medicine
The European Medicines Agency (EMA) has fully validated and granted accelerated assessment to Boehringer Ingelheim's application for European marketing authorization of faldaprevir, a potent second generation oral protease inhibitor. ...
The US Food and Drug Administration (FDA) has approved Janssen Therapeutics' NS3/4A protease inhibitor 'Olysio (simeprevir)' for the treatment of chronic hepatitis C infection as part of an antiviral treatment regimen in combination with ...
For thousands of years, the human race has benefited significantly from the consumption of fresh coconut and its many derivatives. Coconut water, coconut flesh, and coconut oil all possess unique nutritional profiles that make them superior ...
Coconuts are a versatile superfood providing nutrition, health benefits, and amazing medicinal properties all wrapped in one delicious package. Coconuts are totally natural, easily available and affordable; and every part of the fruit is ...
Tags: reason, coconut, home remedy, health, naturally
The health of most of the planet’s population is rapidly coming to resemble that of the United States, where death in childhood is rare, too much food is a bigger problem than too little, and life is long and often darkened by ...
Tags: Burden of Disease
The US FDA's Antiviral Drugs Advisory Committee has recommended approval for Medivir's investigational protease inhibitor simeprevir (TMC435) 150mg capsules for the treatment of genotype 1 chronic hepatitis C in adult patients with ...
Tags: Medivir, Hepatitis C Patients
US-based pharmaceutical firm Merck has received Breakthrough Therapy designation from the US Food and Drug Administration (FDA) for its investigational oral combination regimen MK-5172/MK-8742 for the treatment of chronic hepatitis C virus ...
US-based primary care system Community Health Center (CHC) is expanding its telehealth program to health centers in Delaware under an extension for community healthcare outcomes (ECHO) project. Project ECHO uses video-conferencing and ...
India has partly suspended patents granted to Roche Holding for its breast cancer drug Herceptin, over issues that the patents had not been filed in accordance with the laid down process. An article published in Swiss newspaper Schweiz am ...
Tags: Cancer Drug Patent
Abbott has introduced FDA-approved hepatitis C virus (HCV) genotyping test for patients in the US. The completely automated RealTime HCV Genotype II test determines the specific type or strain of the HCV virus present in the blood of an ...
Tags: US, Health&Medicine, Abbott
Laboratory Corporation of America Holdings (LabCorp) has become the first clinical reference laboratory to offer Roche COBAS AmpliPrep/COBAS TaqMan HCV Test, v2.0, a viral load assay for hepatitis C virus. Designed with enhanced ...
Biopharmaceutical company Gilead Sciences has obtained priority review status for Sofosbuvir new drug application (NDA) from the FDA for the treatment of hepatitis C infection (HCV). The investigational product is an oral nucleotide ...
Tags: Gilead, Sofosbuvir NDA
GlaxoSmithKline (GSK) has acquired a Switzerland-based vaccines company, Okairos, for €250m in cash to boost its existing vaccine platform technology expertise and to continue developing the next generation of vaccines. Under the ...
Tags: Glaxosmithkline, Vaccines Business
Johnson & Johnson's Pharmaceuticals unit Janssen is planning to submit more than 10 new products for regulatory approval and extend the brand pipeline of 25 existing drugs by 2017. The late stage products to be submitted for approval ...
Tags: Johnson&Johnson, New Drugs